Advancing drug development through strategic clinical pharmacology and model-informed drug development (MIDD) expertise
Providing scientific consultation for clinical pharmacology strategy development, dose selection/optimization, clinical study design, data analysis, regulatory support and scientific communication
Advancing drug development and supporting data-driven decisions by leveraging specialized knowledge in pharmacokinetics (PK), pharmacodynamics (PD), and MIDD
Integrating with program team to provide clinical pharmacology representation
Strategic Planning
Study Design
Data Analysis & Interpretation
Dose Optimization
Regulatory Support
Scientific Communication
Clinical pharmacologist with 10+ years of experience in drug development across pharmaceutical industry and academia.
Proven record of designing and executing end-to-end clinical pharmacology strategies from FIH to late-stage development.
Extensive knowledge of clinical pharmacology of biologics (ADC, mAb) and drug development in oncology.
info@biesdorfconsulting.com